Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events pharma payers worldwide recognize quality pro data key decision making
… Decision-Analytic Models Decision-analytic models provide a … depends on the strength of the model structure and the quality of the data, but it must also be flexible, transparent, and …
… your products’ value to patients, physicians, caregivers, payers, and policymakers. With so many public, private, and … coverage policies in the US and disease area concerns worldwide. To get a well-rounded view of your products, we … typically with the following sections: Executive summary: Key product value messages and links to key background …
… Multi-Criteria Decision Analysis Most drug development and commercialization … across its lifecycle—including efficacy, safety, impact on quality of life and functional status, dosing convenience, … target market or country. With access to clinical trial data, outcomes data, and published economic models, we can …
… four years as a reviewer on the Health Care Technology and Decision Sciences Study Section at the Agency for Healthcare Research and Quality. In 2014, she was elected to the ISPOR Board of …
… Advancing Health Equity: The Crucial Role of Pharma and Medtech Developers Share on: November 14, 2023 … costs, and lost workforce productivity. But by having a data-driven understanding of existing health disparities and … seeking to eliminate health disparities—indeed, industries worldwide are renewing their focus on health equity and …
… used in health economic models (for example, to calculate quality-adjusted life years [QALYs] in cost-effectiveness … for health care interventions. They allow regulators, payers, and other stakeholders to incorporate the perceived … and standard gamble - Capture utility data real-time, as events occur, via mobile technology solutions (e.g., …
… economic information affects how patients, providers, payers , and regulators make decisions, and we understand your need for credible, reliable, and high-quality evidence-based analyses. Leverage the wide-ranging … endpoints for your clinical trials Analyze economic data collected in clinical trials Implement comparative …
… or an unapproved use dossier, allows you to communicate key product information—including clinical evidence—to US … such as burden of illness, unmet need, and early clinical data with stakeholders. We can also support your development … key disease and unmet need evidence to US health care decision makers. Getting this valuable information into the …
… potential risks? More importantly, do you have the right data to credibly demonstrate this to regulators, payers, physicians, and patients? You can rely on our … requirements of regulatory and reimbursement stakeholders worldwide. Our integrated team of cross-functional experts …
… can apply the value story to their local markets. Key sections in a GVD include: Value story Disease burden … stakeholders in non-HTA markets and regional and local payers. Objection Handlers Objection handlers are for … will the product influence the clinical pathway? Are there data that can be leveraged at launch to influence …